Start your free 3-day trial — no credit card required, full access included

Evidence - Oophorectomy, laparoscopic, robot-assisted laparoscopy (DaVinci)

  1. Indication

    • Symptomatic cysts: Large or painful cysts that cause discomfort, such as pelvic pain or a feeling of pressure in the abdomen
    • Persistent cysts: Cysts that do not regress on their own and remain for an extended period
    • Risk of torsion: Cysts that pose the risk of ovarian torsion (twisting of the ovary), which can lead to acute pain and emergencies 

    According to a study, the most common benign ovarian cysts were endometriosis cysts and dermoid cysts.

    Reference: 

    1. Lok IH, Sahota DS, Rogers MS, Yuen PM. Complications of laparoscopic surgery for benign ovarian cysts. J Am Assoc Gynecol Laparosc. 2000 Nov;7(4):529-34. doi: 10.1016/s1074-3804(05)60369-6. PMID: 11044507.
    2. Northridge JL. Adnexal Masses in Adolescents. Pediatr Ann. 2020 Apr 1;49(4):e183-e187. doi: 10.3928/19382359-20200227-01. PMID: 32275763.
  2. Complications

    Overall complication rate: The overall rate of complications in laparoscopic procedures for the removal of benign ovarian cysts is approximately 13.3%

    Severe complications: Severe complications occur in about 0.6% of cases. These include injuries to the small intestine and ureters

    Conversion to laparotomy: The necessity to switch from a laparoscopic to an open surgery (laparotomy) is less than 1%

    Postoperative complications: The postoperative complication rate is about 0.79% to 0.89%. The most common postoperative complications include infections and bleeding

    Recurrence rate: The likelihood of recurrence of ovarian cysts after a laparoscopic ovarian cystectomy is approximately 22.6% for endometriosis cysts

    Long-term complications: Long-term complications such as adhesions (scar tissue) and chronic pain occur less frequently but are still relevant. Additionally, the ovarian reserve may be impaired after an ovarian cystectomy, particularly with endometriosis cysts. Therefore, preserving ovarian tissue is crucial for patients who wish to maintain their fertility for the future.

    Reference: 

    1. Lok IH, Sahota DS, Rogers MS, Yuen PM. Complications of laparoscopic surgery for benign ovarian cysts. J Am Assoc Gynecol Laparosc. 2000 Nov;7(4):529-34. doi: 10.1016/s1074-3804(05)60369-6. PMID: 11044507.
    2. Wacharachawana S, Phaliwong P, Prommas S, Smanchat B, Bhamarapravatana K, Suwannarurk K. Recurrence Rate and Risk Factors for the Recurrence of Ovarian Endometriosis after Laparoscopic Ovarian Cystectomy. Biomed Res Int. 2021 Jan 25;2021:6679641. doi: 10.1155/2021/6679641. PMID: 33575338; PMCID: PMC7857866.
    3. Li RY, Nikam Y, Kapurubandara S. Spontaneously Ruptured Dermoid Cysts and Their Potential Complications: A Review of the Literature with a Case Report. Case Rep Obstet Gynecol. 2020 Mar 31;2020:6591280. doi: 10.1155/2020/6591280. PMID: 32292616; PMCID: PMC7150697.
    4. Perlman S, Kjer JJ. Ovarian damage due to cyst removal: a comparison of endometriomas and dermoid cysts. Acta Obstet Gynecol Scand. 2016 Mar;95(3):285-90. doi: 10.1111/aogs.12841. Epub 2016 Jan 24. PMID: 26669273.
  3. Ovarian cysts

    Four types of benign ovarian cysts are most commonly encountered:

    1. functional (follicular and corpus luteum) cysts,
    2. mature cystic teratomas, and
    3. endometriomas.
    4. cystadenomas

    Ovarian cysts are quite common and affect all age groups, both symptomatic and asymptomatic women. In a study by Campbell et al., six percent of 5000 healthy women reported detectable adnexal masses on a transabdominal ultrasound examination. Of these, 90% were cystic, with most diagnosed as simple cysts. About 8% of premenopausal women develop large cysts that require treatment. According to estimates by the National Institutes of Health, 5-10% of women need surgery to remove an ovarian cyst. Of these cysts, about 13-21% are malignant. A two-year interim analysis of the International Ovarian Tumor Analysis Phase 5 (IOTA5) study showed that 80% of ovarian cysts classified as benign on ultrasound either disappeared or required no intervention. Only 12 of the 1919 women in the study received a diagnosis of ovarian cancer, resulting in a two-year cumulative cancer risk of 0.4%. Ovarian cysts are less common after menopause. Postmenopausal women with ovarian cysts have a higher risk of ovarian cancer. A systematic review and meta-analysis by Liu et al. found that the malignancy rate (including borderline tumors) for simple ovarian cysts in postmenopausal women is about 1 in 10,000.

    Functional cysts form in women of reproductive age during folliculogenesis and are of either follicular or corpus luteal origin. These cysts arise during the normal female reproductive process, hence their functional designation. The pathogenesis of follicular cyst formation is complex and related to the release of hormones from the anterior pituitary. In these cases, the traditional feedback mechanisms are not synchronized, and the surge of luteinizing hormone is blunted. As a result, the egg is not released from the follicle, which then does not regress and continues to grow, sometimes to cystic proportions. Corpus luteum cysts develop after ovulation through an unknown mechanism. They can become quite large and twist, which is more often associated with pain and, in some cases, delayed menstruation. Some cysts function autonomously, like those associated with McCune-Albright syndrome, and can reach large sizes.

    Mature cystic teratomas or dermoid cysts are actually benign germ cell tumors that are partially cystic. They can occur over a wide age range, with more than 70% occurring during the reproductive years. They are thought to develop from a single primordial germ cell that has completed meiosis I and is arrested in meiosis II. This theory is supported by the anatomical distribution of teratomas along the migration path of primordial germ cells from the yolk sac to the gonadal ridges. MCTs consist of all three germ layers: ectoderm, mesoderm, and endoderm. They are usually unilateral, measuring 2-4 cm in diameter, and are filled with thick sebaceous material, hair, calcifications, and sometimes teeth. Some are even hormonally active. Unlike simple cysts, teratomas do not resolve spontaneously. Most require surgical intervention. They are more commonly associated with ovarian torsion than other benign cysts. Although dermoid cysts are benign, complications upon rupture include chemical peritonitis, bowel adhesions and obstructions, and abscesses.

    Endometriomas are hormonally active ovarian cysts whose hormonal changes correspond to the phases of the menstrual cycle. The origin of endometriomas has been controversial. Nezhat and colleagues have proposed that there are two types of endometriomas: primary and secondary. According to the authors, primary endometriomas arise as invaginated surface endometrial glands. They develop slowly over time and rarely reach sizes greater than 5-6 cm. They are difficult to remove during cystectomy due to their fibrous capsule. Microscopic examination identifies both endometrial glands and stroma. Secondary endometriomas arise in functional cysts, with some originating from a corpus luteum. These endometriomas are the classic chocolate cysts and contain dark blood. Secondary endometriomas can become quite large and are easily removed. Microscopic examination of a well-sampled specimen often reveals a corpus luteum, endometrial glands, and stroma.

    Cystadenomas are benign epithelial tumors that form cystic structures. They can be serous or mucinous. Serous cystadenomas contain clear, serous fluid and commonly occur in women in their fourth and fifth decades of life. Mucinous cystadenomas are filled with mucinous fluid and can occur unilaterally or bilaterally. These tumors can become large and exert pressure on adjacent organs, leading to symptoms such as bloating, loss of appetite, and constipation. Cystadenomas are typically surgically removed to prevent possible malignant transformation.

    Reference:

    1. Armando E Hernandez-Rey, Teresa Pfaff-Amesse, Michel E Rivlin, Ovarian Cystectomy, Medscape, 2023 Mar 9, https://emedicine.medscape.com/article/1848505-overview?form=fpf Lawrence S Amesse
    2. National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol. 1994 Dec;55(3 Pt 2):S4-14. doi: 10.1006/gyno.1994.1333. PMID: 7835809.
    3. Campbell S, Bhan V, Royston P, Whitehead MI, Collins WP. Transabdominal ultrasound screening for early ovarian cancer. BMJ. 1989 Dec 2;299(6712):1363-7. doi: 10.1136/bmj.299.6712.1363. PMID: 2513964; PMCID: PMC1838264.
    4. Froyman W, Landolfo C, De Cock B, Wynants L, Sladkevicius P, Testa AC, Van Holsbeke C, Domali E, Fruscio R, Epstein E, Dos Santos Bernardo MJ, Franchi D, Kudla MJ, Chiappa V, Alcazar JL, Leone FPG, Buonomo F, Hochberg L, Coccia ME, Guerriero S, Deo N, Jokubkiene L, Kaijser J, Coosemans A, Vergote I, Verbakel JY, Bourne T, Van Calster B, Valentin L, Timmerman D. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study. Lancet Oncol. 2019 Mar;20(3):448-458. doi: 10.1016/S1470-2045(18)30837-4. Epub 2019 Feb 5. PMID: 30737137.
    5. Ross EK, Kebria M. Incidental ovarian cysts: When to reassure, when to reassess, when to refer. Cleve Clin J Med. 2013 Aug;80(8):503-14. doi: 10.3949/ccjm.80a.12155. PMID: 23908107.
    6. Liu YN, Tan X, Xiong W, Dong X, Liu J, Wang ZL, Chen HX. Natural history and malignant potential of simple ovarian cysts in postmenopausal women: a systematic review and meta-analysis. Menopause. 2023 May 1;30(5):559-565. doi: 10.1097/GME.0000000000002163. Epub 2023 Feb 14. PMID: 36787526.
    7. Muechler EK, Florack AJ, Cary D, Kapakis M. Isosexual precocious puberty with luteinized follicular cyst. N Y State J Med. 1982 Aug;82(9):1353-6. PMID: 6957757.
    8. Ayhan A, Bukulmez O, Genc C, Karamursel BS, Ayhan A. Mature cystic teratomas of the ovary: case series from one institution over 34 years. Eur J Obstet Gynecol Reprod Biol. 2000 Feb;88(2):153-7. doi: 10.1016/s0301-2115(99)00141-4. PMID: 10690674.
    9. Linder D, McCaw BK, Hecht F. Parthenogenic origin of benign ovarian teratomas. N Engl J Med. 1975 Jan 9;292(2):63-6. doi: 10.1056/NEJM197501092920202. PMID: 162806.
    10. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005 Feb;18 Suppl 2:S61-79. doi: 10.1038/modpathol.3800310. PMID: 15761467.
    11. Li RY, Nikam Y, Kapurubandara S. Spontaneously Ruptured Dermoid Cysts and Their Potential Complications: A Review of the Literature with a Case Report. Case Rep Obstet Gynecol. 2020 Mar 31;2020:6591280. doi: 10.1155/2020/6591280. PMID: 32292616; PMCID: PMC7150697.
    12. Nezhat F, Nezhat C, Allan CJ, Metzger DA, Sears DL. Clinical and histologic classification of endometriomas. Implications for a mechanism of pathogenesis. J Reprod Med. 1992 Sep;37(9):771-6. PMID: 1453396.
    13. Limaiem F, Lekkala MR, Mlika M. Ovarian Cystadenoma. 2023 Jun 18. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30725635.
  4. Aspiration and fenestration versus ovariectomy

    Aspiration of Cyst Contents:

    • Not recommended: No tissue for histopathology, cytology of cyst fluid unreliable for exclusion of malignancy.
    • Recurrence rate: Up to 65%.
    • Complication rate: 2.6%.
    • Comparison: No better outcomes than simple observation.

    Fenestration:

    • Method: Removal of a full-thickness, square portion of the cyst wall to create a window.
    • Problems less frequent: Compared to aspiration.
    • Risk in malignant cysts: Spillage of malignant cells into the peritoneal cavity possible.
    • Cystectomy still preferred

    Cystectomy:

    • Preferred procedure: For the treatment of benign ovarian cysts.

    Sclerotherapy after Aspiration:

    • Method: Injection of methotrexate, tetracycline, alcohol, or erythromycin after aspiration.
    • Recurrence rate: 4 to 38% in cyst persistence or recurrence.
    • Uncertainty: Efficacy compared to expectant management not sufficiently controlled.

    Reference: 

    1. Zanetta G, Lissoni A, Torri V, et al. Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study. BMJ 1996; 313:1110.
    2. Díaz de la Noval B, Rodríguez Suárez MJ, Fernández Ferrera CB, et al. Transvaginal Ultrasound-Guided Fine-Needle Aspiration of Adnexal Cysts With a Low Risk of Malignancy: Our Experience and Recommendations. J Ultrasound Med 2020; 39:1787.
    3. Mesogitis S, Daskalakis G, Pilalis A, et al. Management of ovarian cysts with aspiration and methotrexate injection. Radiology 2005; 235:668.
  5. literature search

    Literature search on the pages of pubmed.